CM Hospitalar S.A., which is part of Viveo (VVEO3), reported in a material fact released this Monday, August 24, 2026, that it received a notice from B3 because its common shares have been trading below R$ 1.00 since June 26, 2026. The exchange requested that the company disclose the procedures and schedule to bring the share price back into compliance by February 8, 2027, in accordance with B3’s Issuers’ Regulation.
The company stated that if the shares do not spontaneously return to the minimum required level within the granted period, it intends to submit to its governance bodies a proposal for a reverse stock split, defining the split ratio, the treatment of fractional shares, and the amendments to the bylaws. The preliminary timetable calls for a meeting of the board of directors and the fiscal council by January 15, 2027, publication of the notice of meeting and the management proposal by January 18, 2027, and holding a general shareholders’ meeting to resolve on the reverse split by February 8, 2027, on first call.
The company also highlighted that on June 26, 2026, the board of directors approved a capital increase of up to R$ 869,761,072.80, through the issuance of up to 966,401,192 new common shares, at a price of R$ 0.90 per share, a transaction that is still underway. In this context, the company clarified that, if approved, the reverse stock split will only be implemented after the completion of this capital increase.
